CDCN Annual Working Dinner

The CDCN’s Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner helps to disseminate cutting edge Castleman disease research

In light of the global Coronavirus crisis, the Castleman Disease Collaborative Network (CDCN) hosted the 9th Annual “Accelerating Research & Treatment for Castleman Disease,” working dinner in a virtual (online) format on Monday, February 22, 2021, outside of our traditional time during the annual American Society of Hematology Meeting.

The CDCN virtual working dinner was attended by physicians and researchers from around the globe, who are dedicated to advancing the understanding and treatment of Castleman disease. The event served as an opportunity for the CDCN’s network of physicians and researchers to discuss cutting edge research and important issues for patient care.  If you missed the CDCN’s “Accelerating Research & Treatment for Castleman Disease,” Virtual Working Dinner you can view the recording of the presentations here.



Monday, February 22, 2021   

5:30 – 5:55 PM EST [Optional] Poster Session
1: Castleman disease presenting as membranous glomerulonephritis in a middle aged Indian female
Submitted by: Devika Dua
Abstract Link
Poster Link
2: Autoimmune Hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease 
Submitted by: David Boutboul
Abstract Link
 3: Castleman disease: A Brazilian multicentric cohort of a rare hematological disorder
Submitted by: Antonio A. G. S. Brandão
Abstract Link
Poster Link
4: Treatments for TAFRO syndrome in Japan
Submitted by: Hiroshi Kawabata
Abstract Link
Poster Link
6:00 – 6:20 PM EST Welcome and presentation on advances in understanding Castleman disease pathogenesis and treatment
David Fajgenbaum, MD, MBA, MSc
6:20 – 6:35 PM EST Multi-omic investigation of cell types and pathways in iMCD
Ruth-Anne Pai, PhD Candidate
6:35 – 6:50 PM EST CD Spectrum & SPEED 2 iMCD Cytokine Sub-Analysis
Sheila Pierson, MS
6:50 – 7:05 PM EST  Treatment of UCD and IMCD
Frits van Rhee, MD, PhD, MRCP (UK), FRCPath
7:05 – 7:10 PM EST BCD regimen to treat relapse/refractory iMCD
Lu Zhang, MD
7:10 – 7:15 PM EST UCD with MCD-like inflammatory state: Surgical excision is highly effective
Miaoyan Zhang, MD Candidate
7:15 – 7:30 PM EST Discussion Groups
1: Castleman disease clinical focus group
2: Castleman disease translational research focus group
7:30 PM EST  Closing Remarks

This annual meeting is a tremendous example of the power of the CDCN’s collaborative research approach to defeating Castleman disease

The last in-person CDCN Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner was held during the 2019 ASH Meeting in Orlando Florida from December 7th to December 10th at the Rosen Centre. Research related to Castleman disease was showcased in the first hour of the Working Dinner. 


Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left